Megan Griffith

2.6k total citations
36 papers, 1.7k citations indexed

About

Megan Griffith is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Genetics. According to data from OpenAlex, Megan Griffith has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 10 papers in Nephrology and 10 papers in Genetics. Recurrent topics in Megan Griffith's work include Vasculitis and related conditions (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Megan Griffith is often cited by papers focused on Vasculitis and related conditions (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Megan Griffith collaborates with scholars based in United Kingdom, Ireland and United States. Megan Griffith's co-authors include Jeremy Levy, Charles D. Pusey, Tom Cairns, Liz Lightstone, Ruth J. Pepper, H. Terence Cook, David Taube, David Jayne, Marie Condon and Thomas Cairns and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Annals of the Rheumatic Diseases.

In The Last Decade

Megan Griffith

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan Griffith United Kingdom 19 804 758 419 402 296 36 1.7k
Duvuru Geetha United States 24 1.2k 1.5× 459 0.6× 526 1.3× 290 0.7× 440 1.5× 123 2.1k
Giles Walters Australia 18 330 0.4× 334 0.4× 439 1.0× 775 1.9× 153 0.5× 49 1.7k
Cloé Comarmond France 26 1.1k 1.4× 853 1.1× 338 0.8× 446 1.1× 209 0.7× 59 2.5k
Giovanni Banfi Italy 25 471 0.6× 1.2k 1.6× 1.4k 3.4× 617 1.5× 153 0.5× 46 2.5k
W. Joseph McCune United States 23 988 1.2× 1.4k 1.9× 309 0.7× 796 2.0× 372 1.3× 41 2.5k
Y K Onno Teng Netherlands 28 392 0.5× 1.9k 2.5× 664 1.6× 1.4k 3.4× 247 0.8× 107 2.9k
Matthew D. Morgan United Kingdom 21 2.0k 2.5× 952 1.3× 594 1.4× 522 1.3× 761 2.6× 41 2.8k
Magali Colombat France 21 413 0.5× 153 0.2× 278 0.7× 229 0.6× 110 0.4× 92 1.5k
H A Austin United States 18 215 0.3× 1.2k 1.6× 823 2.0× 606 1.5× 74 0.3× 29 2.0k
Shruti Chaturvedi United States 24 126 0.2× 463 0.6× 380 0.9× 769 1.9× 505 1.7× 101 2.0k

Countries citing papers authored by Megan Griffith

Since Specialization
Citations

This map shows the geographic impact of Megan Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Griffith more than expected).

Fields of papers citing papers by Megan Griffith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Griffith. The network helps show where Megan Griffith may publish in the future.

Co-authorship network of co-authors of Megan Griffith

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Griffith. A scholar is included among the top collaborators of Megan Griffith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Griffith. Megan Griffith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McAdoo, Stephen P., Ruth J. Pepper, Maria Prendecki, et al.. (2025). Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis. Kidney International Reports. 10(6). 1874–1885.
2.
Andeen, Nicole K., Vanderlene L. Kung, Rupali S. Avasare, et al.. (2025). Questions and Caveats in Antigen-Defined Membranous Nephropathy. Journal of the American Society of Nephrology. 36(8). 1639–1651.
3.
Bruchfeld, Annette, Fernando Caravaca‐Fontán, Gema Fernández‐Juárez, et al.. (2024). Immunoengineering for autoimmune-kidney disease. Nephrology Dialysis Transplantation. 39(12). 1934–1937. 1 indexed citations
4.
Kanigicherla, Durga, Angie A. Kehagia, L. Manounah, et al.. (2024). Prospective study of the effect of rituximab on kidney function in membranous nephropathy. Clinical Kidney Journal. 17(8). sfae179–sfae179. 1 indexed citations
5.
Turner‐Stokes, Tabitha, Tom Cairns, Candice Clarke, et al.. (2021). Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease. Kidney International Reports. 6(5). 1402–1406. 3 indexed citations
6.
Edwards, Helena, Maria Prendecki, Thomas Cairns, et al.. (2021). Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. Kidney International. 100(6). 1316–1324. 38 indexed citations
7.
Pepper, Ruth J., Stephen P. McAdoo, Sarah Moran, et al.. (2018). A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis. Lara D. Veeken. 58(2). 1119–1119. 58 indexed citations
8.
McAdoo, Stephen P., et al.. (2016). Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series. Lara D. Veeken. 55(8). 1437–1442. 31 indexed citations
9.
McAdoo, Stephen P., Anisha Tanna, Frederick W.K. Tam, et al.. (2014). Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series. Lara D. Veeken. 54(6). 1025–1032. 10 indexed citations
10.
McAdoo, Stephen P., Anisha Tanna, Megan Griffith, et al.. (2013). Focal necrotizing and crescentic glomerulonephritis in patients with normal serum creatinine. La Presse Médicale. 42(4). 753–753. 1 indexed citations
11.
Mansfield, Neil J., Sally Hamour, Ruth M. Tarzi, et al.. (2011). Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis. Nephrology Dialysis Transplantation. 26(10). 3280–3286. 54 indexed citations
12.
Borrows, Richard, Kakit Chan, Marina Loucaidou, et al.. (2006). Five Years of Steroid Sparing in Renal Transplantation with Tacrolimus and Mycophenolate Mofetil. Transplantation. 81(1). 125–128. 20 indexed citations
13.
Loucaidou, Marina, Richard Borrows, Sara E. Marshall, et al.. (2005). Cytokine Polymorphisms Do Not Influence Acute Rejection in Renal Transplantation Under Tacrolimus-Based Immunosuppression. Transplantation Proceedings. 37(4). 1760–1761. 22 indexed citations
14.
Borrows, Richard, Marina Loucaidou, Thomas Cairns, et al.. (2005). Steroid Sparing in Renal Transplantation With Tacrolimus and Mycophenolate Mofetil: Three-Year Results. Transplantation Proceedings. 37(4). 1792–1794. 6 indexed citations
15.
Borrows, Richard, Gary Chusney, Tom Cairns, et al.. (2005). Determinants of Mycophenolic Acid Levels After Renal Transplantation. Therapeutic Drug Monitoring. 27(4). 442–450. 44 indexed citations
16.
Loucaidou, Marina, Richard Borrows, Thomas Cairns, et al.. (2005). Late Steroid Withdrawal for Renal Transplant Recipients on Tacrolimus and MMF Is Safe. Transplantation Proceedings. 37(4). 1795–1796. 9 indexed citations
17.
Borrows, Richard, Gary Chusney, Marina Loucaidou, et al.. (2005). Tacrolimus Monitoring in Renal Transplantation: A Comparison Between High-Performance Liquid Chromatography and Immunoassay. Transplantation Proceedings. 37(4). 1733–1735. 9 indexed citations
18.
Dhaygude, Ajay, et al.. (2004). Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis. Nephron Clinical Practice. 97(4). c154–c159. 7 indexed citations
19.
Griffith, Megan, G. Gaskin, & Charles D. Pusey. (1996). Classification, Pathogenesis, and Treatment of Systemic Vasculitis. Renal Failure. 18(5). 785–802. 9 indexed citations
20.
Griffith, Megan, et al.. (1996). T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clinical & Experimental Immunology. 103(2). 253–258. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duvuru Geetha Breakdown of academic impact, for papers by Giles Walters Breakdown of academic impact, for papers by Cloé Comarmond Breakdown of academic impact, for papers by Giovanni Banfi Breakdown of academic impact, for papers by W. Joseph McCune Breakdown of academic impact, for papers by Y K Onno Teng Breakdown of academic impact, for papers by Matthew D. Morgan Breakdown of academic impact, for papers by Magali Colombat Breakdown of academic impact, for papers by H A Austin Breakdown of academic impact, for papers by Shruti Chaturvedi
Rankless by CCL
2026